Skip to content
lsd.com

Indication

Cognitive Dysfunction

3 registered trials testing Psilocybin, DMT, Ibogaine for this indication, none currently recruiting.

3
Registered trials
0
Recruiting
0
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Cognitive Dysfunction trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 3 trials for Cognitive Dysfunction

TrialStatusPhaseSubstanceSites
Trifecta Research StudyNCT06810765 · Johns Hopkins UniversityWithdrawnPhase 2dmt, ibogaine1
An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X SyndromeNCT05832255 · Nova Mentis Life Science CorpSuspendedPhase 2psilocybin1
Trifecta Research StudyNCT07717866 · Axial Therapeutic ResearchActive, not recruitingN/Admt, ibogaine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.